Startups
NeoPhore

NeoPhore

https://neophore.com

Small molecule neoantigen immuno-oncology therapies developer.

Summary

Seedtable Score
  • 42
Locations
Company Size
  • 1 to 10 employees
Last Stage Round
  • Series B
Industry

Total funding Amount

$45M

Fundraising History

  • Feb 01 '24 Series B
    $12M
  • Jan 19 '23 Series B
    $7.4M
  • Mar 01 '21 Series B
    $21M

Investors

  • Sixth Element Capital
    Series B
  • 3B Future Health Fund
    Series B
  • Astellas Venture Management
    Series B
  • Claris Ventures
    Series B